Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
Román Pérez-Soler(Cancer Clinic), Philip Bonomi(Rush University Medical Center)
Cited by 1,085
Related Papers
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with Gefitinib
|Journal of Thoracic Oncology|2007|40
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
|PubMed|1986|39
PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
|British Journal of Cancer|2011|20